← Back to Clinical Trials
Recruiting NCT06562140

NCT06562140 Multidimensional Examination of Patients with Colorectal and Anal Cancer

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06562140
Status Recruiting
Phase
Sponsor University of Pecs
Condition Colorectal Cancer
Study Type OBSERVATIONAL
Enrollment 300 participants
Start Date 2024-08-15
Primary Completion 2025-09-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 80 Years
Study Type OBSERVATIONAL
Interventions
No intervention - cross-sectional observational study

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 300 participants in total. It began in 2024-08-15 with a primary completion date of 2025-09-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of our cross-sectional research is to assess changes in physical activity, functional capacity, and health status in individuals with colorectal and anal carcinoma using subjective measurement tools, with particular focus on those suffering from incontinence, through a cross-sectional study. Additionally, the research involves the Hungarian adaptation and validation of the quality of life questionnaire for colorectal cancer (EORTC QLQ-CR29), quality of life questionnaire for anal cancer (EORTC QLQ-AN27), and Fecal Incontinence Severity Index (FISI)" questionnaires.

Eligibility Criteria

Inclusion Criteria: * adult (18-80 years) patients with a diagnosis of colorectal or anal carcinoma Exclusion Criteria: * Neuromuscular diseases * severe congenital musculoskeletal and other disorders, * severe psychiatric illness, lack of cooperation, * undergone other surgical procedures within the past year.

Contact & Investigator

Central Contact

Alexandra Makai, PhD

✉ alexandra.makai@etk.pte.hu

📞 +36307213156

Frequently Asked Questions

Who can join the NCT06562140 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Colorectal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06562140 currently recruiting?

Yes, NCT06562140 is actively recruiting participants. Contact the research team at alexandra.makai@etk.pte.hu for enrollment information.

Where is the NCT06562140 trial being conducted?

This trial is being conducted at Pécs, Hungary, Pécs, Hungary.

Who is sponsoring the NCT06562140 clinical trial?

NCT06562140 is sponsored by University of Pecs. The trial plans to enroll 300 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology